PF-4211
PF-4211 is a selective non-catechol D1R agonist with a Ki value of 2.2 μM.. PF-4211 activates adenylate cyclase by binding to D1R, thereby increasing intracellular cAMP levels. PF-4211 can be used in research related to Parkinson's disease and schizophrenia.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2292115-41-2
- Fòrmula: C17H13N3O2
- Peso molecular:291.30
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
Ver todos los productos específicos de isoformas Dopamine Receptor
More
Actividad biológica
Descripciòn
IC50 & Target
[2]|
Human D1 Receptor 2519 nM (EC50) |
In Vitro
PF-4211 (Compound 6) acts as a partial agonist at the hD1 receptor in HEK293 cells overexpressing hD1, with a geometric mean functional EC50 of 2.293 μM and 37% maximal effect relative to dopamine[1].
PF-4211 binds directly to the hD1 receptor with a geometric mean binding Ki of 2.2 μM[1].
PF-4211 (11-point concentration response curve with half-log increments; 30 min) acts as a partial agonist at human D1 receptors expressed in HEK293 cells, with an EC50 of 2519 nM and a maximum efficacy of 42% relative to dopamine[2].
PF-4211 (10-10-10-4 M; 30 min) induces a dose-dependent increase in cAMP in hD1R-expressing HEK293 cells, with a lower maximum efficacy than dopamine and optimized non-catechol analogs[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 2292115-41-2
-
Peso molecular 291.30
-
Fòrmula C17H13N3O2
-
SMILES
CN1N=CC=C1C2=CC=C(C=C2)OC3=NC=CC4=C3C=CO4
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Davoren JE, et al. Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization. Journal of medicinal chemistry. 2018 Dec 27;61(24):11384-11397. [Content Brief]
[2]. Gray DL, et al. Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor. Nature communications. 2018 Feb 14;9(1):674. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
PF-4211 Related Classifications
HY-149168 Related Classifications
Powered by Bioz